Literature DB >> 25932321

Person-centric clinical trials: defining the N-of-1 clinical trial utilizing a practice-based translational network.

Frederick A Curro1, Dennis A Robbins2, Frederick Naftolin3, Ashley C Grill4, Don Vena5, Louis Terracio6.   

Abstract

A person-centric clinical trial is inclusive of both the investigator and the person and as such represents point-of-use data generated at the practice level and encompasses both health and disease. Raising the clinical encounter to a research encounter and providing an infrastructure to support a level of quality assurance creates a synergy for efficiency for healthcare delivery. The interface of translational studies and clinical research poses an opportunity, whereby person-centricity can support transparency, facilitate informed consent, improve safety, enhance recruitment and compliance, improve dissemination of results, implement change and help close the translational gap. The model represents robust clinical data from persons of record allowing for improved interpretation of drug/device side-effects and for regulatory reviewers to expedite the approval process.

Entities:  

Keywords:  clinical trials; comparative effectiveness; healthcare infrastructure; patient-reported outcomes; person-centric; regulatory change

Year:  2015        PMID: 25932321      PMCID: PMC4410815          DOI: 10.4155/cli.14.126

Source DB:  PubMed          Journal:  Clin Investig (Lond)        ISSN: 2041-6792


  19 in total

1.  A short history of primary care practice-based research networks: from concept to essential research laboratories.

Authors:  Larry A Green; John Hickner
Journal:  J Am Board Fam Med       Date:  2006 Jan-Feb       Impact factor: 2.657

2.  Does comparative-effectiveness research threaten personalized medicine?

Authors:  Alan M Garber; Sean R Tunis
Journal:  N Engl J Med       Date:  2009-05-07       Impact factor: 91.245

3.  Preparing for responsible sharing of clinical trial data.

Authors:  Michelle M Mello; Jeffrey K Francer; Marc Wilenzick; Patricia Teden; Barbara E Bierer; Mark Barnes
Journal:  N Engl J Med       Date:  2013-10-21       Impact factor: 91.245

4.  AHRQ series paper 2: principles for developing guidance: AHRQ and the effective health-care program.

Authors:  Mark Helfand; Howard Balshem
Journal:  J Clin Epidemiol       Date:  2009-08-27       Impact factor: 6.437

5.  Advantages of the dental practice-based research network initiative and its role in dental education.

Authors:  Frederick A Curro; Ashley C Grill; Van P Thompson; Ronald G Craig; Don Vena; Analia V Keenan; Frederick Naftolin
Journal:  J Dent Educ       Date:  2011-08       Impact factor: 2.264

6.  Expanding patient involvement in care. Effects on patient outcomes.

Authors:  S Greenfield; S Kaplan; J E Ware
Journal:  Ann Intern Med       Date:  1985-04       Impact factor: 25.391

7.  Person-centric clinical trials: an opportunity for the good clinical practice (GCP)-practice-based research network.

Authors:  Frederick A Curro; Dennis A Robbins; Michael L Millenson; Chester H Fox; Frederick Naftolin
Journal:  J Clin Pharmacol       Date:  2013-07-19       Impact factor: 3.126

Review 8.  Translational research and the evolving landscape for biomedical innovation.

Authors:  Kenneth I Kaitin
Journal:  J Investig Med       Date:  2012-10       Impact factor: 2.895

9.  Person-centric clinical trials: Ethical challenges in recruitment and data transparency for improved outcomes.

Authors:  Dennis A Robbins; Frederick A Curro; John Mattison
Journal:  J Clin Pharmacol       Date:  2014-04-22       Impact factor: 3.126

10.  Evolution and translation of research findings: from bench to where?

Authors:  John P A Ioannidis
Journal:  PLoS Clin Trials       Date:  2006-11-17
View more
  1 in total

1.  The NUDGE trial pragmatic trial to enhance cardiovascular medication adherence: study protocol for a randomized controlled trial.

Authors:  Russell E Glasgow; Christopher E Knoepke; David Magid; Gary K Grunwald; Thomas J Glorioso; Joy Waughtal; Joel C Marrs; Sheana Bull; P Michael Ho
Journal:  Trials       Date:  2021-08-11       Impact factor: 2.728

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.